ALL Metrics
-
Views
-
Downloads
Get PDF
Get XML
Cite
Export
Track
Systematic Review

The therapeutic effect and safety profile of extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: a systematic review

[version 1; peer review: 1 approved with reservations]
PUBLISHED 18 Oct 2023
Author details Author details
OPEN PEER REVIEW
REVIEWER STATUS

Abstract

Background: Extracorporeal Shockwave Therapy (ESWT) has been indicated to relieve local perineal symptoms caused by Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS). Current research has examined the efficacy of ESWT in CPPS patients. Different types of energy generators for ESWT lead to development of different clinical protocols for treatment of CP/CPPS. Therefore in this review, we aimed to compare the clinical protocol, efficacy and safety profile of all these different ESWT machines in CP/CPPS treatment.
Methods: A systematic literature search of 3 search engines (PubMed, Scielo, and Science Directs) was undertaken using the following keywords: Chronic Prostatitis, Chronic Pelvic Pain Syndrome, and Extracorporeal Shockwave Therapy. A systematic review was conducted in accordance with Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA) guidelines. This review included original studies that evaluated the efficacy and clinical protocol of Extracorporeal Shockwave Therapy and Chronic prostatitis or Chronic Pelvic Pain Syndrome that are fully written in English with full-text articles readily available. This article excluded letters to the editor, reviews, and editorials about prostatitis other than CPPS.
Results: The search strategy yielded 8 journals that meet the inclusion and exclusion criteria from all 3 search engines. These 8 studies included 3 different types of energy generators (Piezoelectric, Electropneumatic, and Electromagnetic) with different protocols applied. All 3 types of energy generators of ESWT can effectively decrease all domains of CPSI score within 12 months of follow-up (P-value 0,05). The limitations of this systematic review include the restricted variety of energy generators with the lack of openly registered protocols.
Conclusions: In Conclusion, ESWT provides significant improvement in clinical symptoms as compared to oral medications alone. These therapeutic effects are also observed in all different types of energy generators with different clinical protocols with similar safety profiles.

Keywords

Chronic Prostatitis, Chronic Pelvic Pain Syndrome, ESWT, Protocol.

Introduction

Prostatitis is an inflammation of the prostate gland that may be detrimental to the quality of life, although not life-threatening. The debates about the definition of Chronic Prostatitis (CP)/Chronic Pelvic Pain Syndrome (CPPS) have been ongoing for decades.1 According to the most recent version of the National Institute of Health (NIH) consensus classification, the diagnosis of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) relies upon the detection of leukocytes in expressed prostatic secretions (EPS), urine post prostatic massage (VB3), or seminal fluid analysis. These criteria doubled as many patients into the category of CP/CPPS as compared to the previous classification system.2 The inherent diversity of the illness gives rise to a significant amount of variation in establishing clinical diagnosis CP/CPPS. According to the most recent NIH classification, CPPS is defined as chronic nonbacterial prostatitis (group III).3 Approximately 5 to 10% of prostatitis have been linked to a bacterial infection. The average prevalence of CPPS varies from 6.9% in North America to 12.2% in Africa, with Europe at 8.6%, Asia at 7.5%, and Australia at 7.5%.2 The remarkably consistent rate across continents suggests that the disease’s development is not influenced by environmental risk factors. Group III of the NIH Classification is subdivided into two subtypes accoeding to the presence of leukocytes in EPS, VB3 and seminal analysis. Lower urinary tract syndrome (LUTS) has frequently been reported as one of the most prominent symptoms in people with CPPS, frequently manifesting as discomfort and difficulties urinating. Therefore, the NIH determined that the scoring system should be based on three large domains (degree of pain, lower urinary tract symptoms, and quality of life) that may be filled out by patients in order to interpret symptom quality into quantitative illness severity.14

Numerous etiologies and pathogenic mechanisms for chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) have been proposed. The authors propose a potential involvement of immunological, neurological, endocrine, and psychological aspects. The implications of these findings on the indigenous bacterial flora in the prostate gland, and its role in triggering the inflammatory response, are also considered. Taken as a whole, it is apparent that the prostate cannot be completely attributed as the only origin of symptoms in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS).4

There are various medical treatments available for the management of CP/CPPS although unfortunately with inconsistent efficacy. These medications include 5-alpha reductase inhibitor, alpha-receptor blockers, antibiotics, anti-inflammatory medications and analgesics that have been used individually or in combination.3,5 Physiotherapy, botulinum toxin A intraprostatic injection, trigger-point massage, electromagnetic treatment, laser coagulation, invasive neuromodulation, balloon dilation, thermotherapy are examples of alternative therapies.5 Unfortunately, these treatments have not proven universally effective in the treatment of CP/CPPS. Currently, there is no causative or standard treatment for CP/CPPS. As stated in the European Association of Urology’s guideline, individuals with CP/CPPS should be handled in a multidisciplinary and multispecialty settings, considering all of the symptoms. Recently, ESWT has been suggested as a potential treatment for alleviating localized perineal discomfort associated with CP/CPPS.4

ESWT has been recommended as an option for alleviating localized perineal discomfort caused by CP/CPPS. Current research has examined the efficacy of perineal ESWT in CPPS patients. ESWT may alleviate pain through multiple pathways. The mechanisms of how ESWT affects pain include hyperstimulating of nociceptors, repairing tissue through revascularization processes, also lowering muscular tone and stiffness.6 Previous research on the application of ESWT to orthopaedic pain disorders proposed the stated processes. Similar mechanisms of action have been hypothesized as pain-altering methods by which ESWT may treat CPPS patients.7 Up until now, there are a number of different ESWT machinery that applies different technology ranging from Focused ESWT (F-ESWT) such as piezoelectric, electrohydraulic as well as electromagnetic and radial ESWT (R-ESWT) such as electropneumatic energy generator.6,7 This different machineries with different types of energy generators leads to different clinical protocols for treatment of CP/CPPS. Therefore, we attempt to evaluate all the protocols for different ESWT machines. Additionally, this review also aimed to compare the clinical efficacy as well as safety profile of all these different ESWT machines in CP/CPPS treatment.

Methods

Evidence acquisition

Search methodology and criterion for selection

The present systematic review was conducted using the guidelines established by the Preferred Reporting Items for Systematic Review and Meta-analysis (PRISMA). A comprehensive review of the literature was conducted by searching three different databases, which are PubMed, Scielo, and Science Directs. The search was carried out using the terms “Chronic Prostatitis” OR “Chronic Pelvic Pain Syndrome” AND “Extracorporeal Shockwave Therapy”. The keywords used were the same across all databases. The scope of the search was restricted to scholarly articles that were published during the past ten years. The articles included in this review were chosen according to specific criteria for inclusion. These criteria covered articles written in English, articles that examined the effectiveness and clinical procedure of Extracorporeal Shockwave Therapy in relation to Chronic Prostatitis or Chronic Pelvic Pain Syndrome, and original studies that had easily accessible full-text articles. This article excludes other sorts of writings, such as letters to the editor, reviews, and editorials, that discuss prostatitis types other than chronic pelvic pain syndrome (CPPS).

The two investigators (M and IAD) had conducted the initial screening from the titles and abstracts independently. Subsequently, a comprehensive evaluation was conducted on the whole texts of publications that were considered possibly necessary, as well as those for which a conclusive determination could not be reached just based on the abstract. The search approach employed in this study resulted in a total of 67 findings across the three aforementioned databases. The author screened every abstract to find articles. Consequently, 59 articles were excluded, leaving 8 articles to be included in this review for further investigation.

Quality evaluation

The quality of each randomized controlled study was assessed using an instrument by Sterne et al.8 In order to evaluate the potential for bias in experimental research, an assessment was conducted across six domains that pertain to the internal and external validity of these investigations. These domains include the selection of the reported result, measurement of the outcome, missing outcome data, randomization procedure, deviation from intended treatments, and overall bias (Figure 1). A score was assigned to each domain, namely, yes, probably yes, probably no, and no. The studies were categorized into three levels of bias risk, namely low, moderate, and high, according to the overall assessment made by the algorithm for each randomized controlled trial research. In the context of cohort studies, the evaluation encompassed seven distinct categories, namely: participation selection, confounding bias, deviation from intended interventions, intervention classification, outcome measurement, and selection of reported results. A score was assigned to each domain, namely yes, probably yes, probably no, and no. The studies were categorized into four groups based on the algorithm’s comprehensive assessment, indicating varying levels of bias: low, moderate, serious, and critical.

c93f9681-b1bc-47f0-aba5-787405272c64_figure1.gif

Figure 1. Risk of bias.

Data collection

The data from the chosen articles were extracted by two authors (M and IAD) separately. This extraction process involved utilizing a standardized form to collect information such as the publication year, authors, clinical protocol, efficacy of Extracorporeal Shock Wave Therapy (ESWT), and its impact on chronic prostatitis or chronic pelvic pain syndrome. The collected data was then assessed using the National Institutes of Health Chronic Prostatitis Symptom Index (NIH-CPSI) scoring system. Any inconsistencies in the retrieved data were resolved by discussion and consultation of the original article in order to reach an agreement.

Results

Our search strategy gathered 8 journals that meet the inclusion and exclusion criteria from 3 search engines. From the 8 studies that have been included, the article originated from 8 different countries (China, Greece, Iran, Jordan, Montenegro, Saudi Arabia, South Korea, and Taiwan). From the risk of bias assessment, no study was found to have high risk of bias. From the included studies, the main energy generator used in the paper were mostly electromagnetic (EM), 1 study with piezoelectric (PE) and 1 study with electropneumatic (EP). Energy flow density is counted in mJ/mm2 to generalize the measurement. The protocols that had been compared in this review were pulses counted, energy flow density, frequency, duration of treatment and type of energy generator. CPSI score was evaluated as a benchmark for clinical outcome.

Patient characteristic

All included studies in this review only recruited men older than 18 year of age that have been diagnosed with CPPS/Group III prostatitis. Despite CPPS varies in 2 subgroups (IIIA and IIIB) most studies only include prostatitis group IIIB and only 2 studies include both IIIA and IIIB group of prostatitis. Baseline CPSI Score for total domain ranges from 25 to 31 points with different follow up timings in each study (ranging from 1 month to 12 months after ESWT treatment).

Clinical protocol

As listed in Table 1, the protocol that mostly used was electromagnetic energy generator with 0.25 mJ/mm2 energy flow density, 3000 pulses counted and 3 Hz of frequency once a week. Every study that stated in this review had a significancy in statistic (p<0.05). Electropneumatic protocol used in 1 cohort study that have been published by Ghazi et al. using Roland-Pagani brand from Italy with 2500 pulses and 3 Hz of frequencies that generated 0.25 mJ/mm2 energy in 1 session of ESWT.9 That study conduct 1 session of ESWT per week and lasted for 4 sessions. The result was the ESWT treatment statistically significant to reduce the symptoms of CP/CPPS by decreasing the CPSI score in most domain as the time followed up progressively (p-value<0.05).9 Meanwhile piezoelectric machine was used in only 1 RCT study using Lubisone brand machine from South Korean with 3000 pulses and 3 Hz of frequencies that generate 0.25 mJ/mm2 per session. This study conducted 1 session per week for along 12 sessions and resulted in statistically significant reducing the CPSI score in all domain compared to the placebo (p-value<0.05).10 On the other hand, one paper from Mykoniatis et al. comparing 2 different protocol for ESWT in CP/CPPS. They compared between group of 1 session per week and 2 sessions per week for overall 6 sessions applied and resulted in statistically insignificant for both groups compared (p-value>0.05) but statistically significant compared to the baseline (p-value< 0.05).11

Table 1. Clinical Protocol of ESWT for CP/CPPS Treatment.

AuthorYear of publicationBrandTechnologyPulsesFlow densityFrequencyDuration of treatmentDuration of observationsType of studyCountry
Al Edwan GM, et al.92017Roland pagani ES.WTElectropneumatic25000.25 mJ/mm23 Hz1×/week 4 session1 yearcohortJordan
Wu WL, et al.152021storzElectromagnetic30000.25 mJ/mm24 Hz1×/week 6 session1 yearcohortTaiwan
Kim KS, et al.172021CenowaveElectromagnetic30000,26 mJ/mm23 Hz1×/week 4 session1 monthRCTSouth Korea
Sakr AM, et al.162022storzElectromagnetic30000.25 mJ/mm24 Hz1×/week 4 session1 yearRCTSaudi Arabia
Mykoniatis I, et al.112021DornierElectromagnetic50000.096 mJ/mm25 Hz1×/week and 2x/week 6 session3 monthRCTGreece
Rayegani SM, et al.142020StorzElectromagnetic30000.25 mJ/mm23 Hz1×/week 4 session3 monthRCTIran
Zhang ZX, et al.122019StorzElectromagnetic30000,18 mJ/mm210 Hz1×/week 8 session3 monthRCTChina
Pajovic B, et al.102016LubisonePiezoelectric30000.25 mJ/mm23 Hz1×/week 12 session9 monthRCTMontenegro

Clinical improvement

From 8 studies that have been yielded, 2 of them are cohort and the rest are clinical trial. 2 cohort studies showed that the clinical improvement were present for all time follow up CPSI scoring regard from the baseline for all domain (p-value<0.05). Otherwise, study from Zhang et al., stated that there was no significancy between the combination of ESWT and oral triple therapy group and oral triple therapy medication group without ESWT intervention.12 All of the study result containing the clinical improvement by CPSI Scoring summarized in Tables 2, 3 and 4.

Table 2. Univariate and bivariate analysis from cohort studies on ESWT effect on each domain of CPSI.

AuthorYear of publicationMethodSubject amountBivariate (Mean differences (p-value))
Baseline-1 monthBaseline-3 monthBaseline-6 monthBaseline-12 month
PainUrinatingQuality of lifeTotalPainUrinatingQuality of lifeTotalPainUrinatingQuality of lifeTotalPainUrinatingQuality of lifeTotal
Al Edwan GM, et al.92017Cohort41N/AN/AN/AN/AN/AN/AN/AN/A3.5(<0.05)2.7(<0.05)2.5(<0.05)8.7(<0.05)3.1(<0.05)2.7(<0.05)2.3(<0.05)8.2(<0.05)
Wu WL, et al.152021Cohort2153.29(<0.0001)1.17 (0.0003)2.39(<0.0001)6.85(<0.0001)N/AN/AN/AN/A4.87 (<0.0001)2(0.0001)2.5 (<0.0001)9.38(<0.0001)6.93 (<0.0001)2.64(<0.0001)4.68 (<0.0001)14.29 (<0.0001)

Table 3. Comparison of ESWT and placebo group on ESWT effect on each domain of CPSI.

AuthorYear of publicationMethodSubject amountPain domain
Baseline1 month3 months6 months12 months
ESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-value
Kim KS, et al.172021RCT3013.9±2.911.8±2.80.0539.8±3.913.3±2.70.007N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sakr AM, et al.162022RCT155N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Rayegani, et al.142020RCT3113.06±6.2914.67±5.050.448.81±3.3512±3.980.028±3.8911.53±3.980.01N/AN/AN/AN/AN/AN/A
Zhang ZX, et al.122019RCT50N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pajovic B, et al.102016RCT6015.9±3.3114.5±3.22>0.05N/AN/AN/A4.83±2.548.66±5.61<0.056.63±3.7310.9±3.7<0.05N/AN/AN/A
AuthorYear of publicationMethodSubject amountUrinating domain
Baseline1 month3 months6 months12 months
ESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-value
Kim KS, et al.172021RCT304.3±2.73.9±1.70.6343.5±2.84.6±2.00.136N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sakr AM, et al.162022RCT155N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Rayegani, et al.142020RCT314.75±2.8174.87±1.760.892.5±1.364±1.690.012.56±1.094±1.3630.003N/AN/AN/AN/AN/AN/A
Zhang ZX, et al.122019RCT50N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pajovic B, et al.102016RCT605.03±2.415.76±3.04N/AN/AN/AN/A2.2±0.842.1±1.34<0.052.1±0.862.8±1.1<0.05N/AN/AN/A
AuthorYear of publicationMethodSubject amountQuality of life domain
Baseline1 month3 months6 months12 months
ESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-value
Kim KS, et al.172021RCT3010.0±1.99.0±1.90.1646.6±2.59.1±1.80.004N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sakr AM, et al.162022RCT155N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Rayegani, et al.142020RCT317.69±2.758.33±1.750.443.94±1.345.93±1.620.0012.81±1.046±1.3090.0001N/AN/AN/AN/AN/AN/A
Zhang ZX, et al.122019RCT50N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pajovic B, et al.102016RCT609.96±1.89.1±1.51N/AN/AN/AN/A2.9±1.645.36±3.8<0.054.03±2.556.06±3.64<0.05N/AN/AN/A
AuthorYear of publicationMethodSubject amountTotal domain
Baseline1 month3 months6 months12 months
ESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-valueESWT (mean±SD)Placebo (mean±SD)p-value
Kim KS, et al.172021RCT3028.1±6.524.7±4.40.09619.9±8.227.0±4.80.002N/AN/AN/AN/AN/AN/AN/AN/AN/A
Sakr AM, et al.162022RCT15529.52±5.9628.92±5.690.4718.77±4.8728.92±5.69<0.0115.34±4.5428.92±5.69<0.0116.27±4.9128.92±5.69<0.0116.88±5.1230.15±5.74<0.01
Rayegani, et al.142020RCT3125.5±8.9827.87±7.280.4215.25±4.2821.93±5.390.00113.38±4.721.53±4.50.0001N/AN/AN/AN/AN/AN/A
Zhang ZX, et al.122019RCT5028.52±4.0728.05±2.960.66819.12±2.9219.65±2.760.53910.44±2.211.10±1.730.403N/AN/AN/AN/AN/AN/A
Pajovic B, et al.102016RCT6031.06±7.7529.3±6.38N/AN/AN/AN/A10.16±3.9916.8±9.03<0.0511.63±5.8616.1±6.48<0.05N/AN/AN/A

Table 4. Comparison between once a week and twice a week of ESWT sessions in CP/CPPS patients.

AuthorYear of publicationMethodSubject amountPain domain
Baseline1 month3 months6 months12 months
1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value
Mykoniatis, et al.112021RCT non placebo5012.3±2.124.6±4.50.514.8±4.316±4.80.415.6±3.915.9±50.8N/AN/AN/AN/AN/AN/A
AuthorYear of publicationMethodSubject amountUrinating domain
Baseline1 month3 months6 months12 months
1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value
Mykoniatis, et al.112021RCT non placebo502.8±2.83.4±2.70.42.9±2.33.4±2.60.53.1±2.43.4±2.30.7N/AN/AN/AN/AN/AN/A
AuthorYear of publicationMethodSubject amountQuality of life domain
Baseline1 month3 months6 months12 months
1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value
Mykoniatis, et al.112021RCT non placebo508.3±1.28.5±1.20.74.8±1.65.333±1.70.35±1.75±1.20.9N/AN/AN/AN/AN/AN/A
AuthorYear of publicationMethodSubject amountTotal domain
Baseline1 month3 months6 months12 months
1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value1×/week2×/weekp-value
Mykoniatis, et al.112021RCT non placebo5023.6±5.124.6±4.50.514.8±4.316±4.80.415.6±3.915.9±50.8N/AN/AN/AN/AN/AN/A

Discussion

ESWT machinery

Pressure waves are well-established oscillating waves that have The capacity for propagation across various mediums such as gases, liquid and solid. As mentioned before, shockwaves are a form of pressure wave characterized by nonlinearity and a brief duration of rise time, often lasting for a maximum of 10 seconds. The negative and positive phases of shockwaves have distinct outcomes on the interfaces between different tissues characterized by differing densities. During the positive phase, it is possible for high-pressure shockwaves to either impact an interface and undergo reflection or traverse through it and gradually undergo absorption. In the negative phase, commonly mentioned to as the tensile phase, the shockwave induces cavitation at the interfaces of the tissue, leading to the making of air bubbles. Subsequently, the bubbles undergo implosion at a significant velocity, so producing a further series of shockwaves or fluid microjets.13

There are two distinct categories of ESWT shockwaves: Focused ESWT (FSWT) and Radial ESWT (RSWT). FSWT is distinguished by the creation of a pressure field that converges at certain depths inside particular tissues, resulting in reaching a level of maximal pressure at the adjustable focus. In the context of medical practice, the utilization of both concentrated shock waves and radial pressure waves is seen. Radial pressure waves are sometimes denoted as radial shock waves, however it is important to note that this terminology needs to align with the precise use in the field of physics. Shock waves and pressure waves show differences not only in their generating mechanisms, but also in the physical parameters often employed and the depths of therapeutic tissue penetration they may attain. Meanwhile FSWT treat at certain waves, RSWT apply the linear effect on every layer of the tissue. Therefore, FSWT are proposed to have a role at urologic intervention including CP/CPPS while RSWT are proposed to have a role at musculoskeletal problem.

The energy generator that utilized to make RSWT are different from FSWT. RSWT utilized electropneumatic (EP) to produce wave meanwhile FSWT utilize 3 type of generators: Electrohydraulic (EH), Electromagnetic (EM), and Piezoelectric (PE)

  • 1. Electropneumatic (EP) sources generate a plasma bubble in close proximity to a para-ellipsoidal reflector with the application of high-energy release between two electrodes immersed in water. The process of plasma expansion initiates the formation of a shock wave, which subsequently undergoes reflection by a reflector and is then directed towards a secondary target tissue focus.

  • 2. The utilization of electromagnetic (EM) sources using either cylindrical or flat coils is also common. In the initial system, a coil is employed to transmit a high-energy pulse in a direction opposite to that of a metallic membrane. The electromagnetic field produced by the coil induces a rapid bending of the membrane, creating pressure waves inside a fluid medium. A lens is capable of concentrating waves, causing them to undergo a steepening process that ultimately results in the formation of a shockwave in close proximity to the focal point. The next electromagnetic producing source comprises a tubular coil and a metallic membrane positioned within a parabolic reflector that is filled with fluid. The presence of a magnetic field induces displacement of the membrane in a direction away from the coil. Following contemplation by the reflector, a radial auditory pulse is generated and directed toward the focal point of the system.

  • 3. Piezoelectric (PE) generators produce shockwaves through the use of a high-energy release, a configuration of PE devices adhered to the interior surface of a cylindrical backing, which is situated within a cavity filled with fluid is utilized. Each component undergoes expansion, generates a propagating pressure pulse that disperses in the direction of the focus area of the given configuration. The concentration of pressure pulses and nonlinear effects in the focal region results in the formation of a shockwave.7

The production of focused shockwaves in water is facilitated by the comparable acoustic impedance of water and biological tissue. Therefore, the process of reflection is diminished. Electrohydraulic pulse (EP), electromagnetic pulse (EM), and piezoelectric effect (PE) all employ water as a medium for generating intense shockwaves, hence exhibiting a similarity. However, there is a clear distinction in the instant when shockwaves are formed. Electro-pneumatic (EP) generators are capable of producing shockwaves instantly following the spark gap, in contrast to electromagnetic (EM) and piezoelectric (PE) generators which exhibit a delay in the nanosecond range due to wave focalization.13

Although the clinical efficacy of the treatment, the underlying mechanism of action of ESWT remains unclear. During the year of 1997, Haupt put up four potential pathways for the stages of tissue response to ESWT.13

  • 1. Physical stage: this stage reveals that the shockwave generates a positive pressure that results in energy absorption, deflection, refraction, and transmission into cells and tissues. Further investigations indicated that ESWT elicits physical phenomena like cavitation, enhanced process of ionization in biological molecules, and its impact on the permeability of cellular membranes by applying a force generated by negative pressure.13

  • 2. The physicochemical stage of ESWT induces the release of biomolecules, including adenosine triphosphate (ATP), which in turn stimulates cellular signaling pathways.13

  • 3. Chemical stage: during this stage, shockwaves induce modifications in the activity of ion channels located in the cellular membrane, as well as the movement of calcium within cells.13

  • 4. Biological stage: Previous research has demonstrated that extracorporeal shock wave therapy (ESWT) has the ability to modulate various biological processes. These include angiogenesis, anti-inflammatory, and promote wound healing through the activation of Wnt3, Wnt5a, and beta-catenin.13

In CP/CPPS itself, the main therapeutic pathway of ESWT are in both physical and physiochemical phase which hyperstimulate the nociceptor and release the muscle stiffness to alleviate symptoms in all domain of CPSI scoring.7

ESWT treatment protocol

The machinery in this systematic review of focused ESWT separated into 3 kind of energy generator (EP, EM, and PE). All of the 3 machine shared the same amount of shockwave energy with different protocols. Thus, every ESWT operator need to know the basic protocol that are usually used in CP/CPPS for each machine regardless the brand of the machine itself. Ghazi et al. utilized Roland Pagani ES.WT four sessions weekly (2500 Pulses, energy flow density of 0.25 mJ/mm2, and 3Hz).9 Meanwhile PE machine that was used by Pajovic et al. used Lubisone machine 12 sessions weekly (3000 pulses, 0.25 mJ/mm2 of energy flow density and 3 Hz).10 And lastly EM machine using Storz and Cenowave machine, have differed protocol in some studies for 4-6 sessions weekly (3000 pulses, 0.096-0.25 mJ/mm2 of energy flow density and 3-10 Hz).12,1417 Interestingly, one study from Mykoniatis et al., stated that there were no significant differences of CPSI result between undergoing ESWT treatment once a week or twice a week. However all ESWT clinical protocols in this systematic review have shown significant improvement of CPSI scores compared to baseline.11

ESWT effect on pain domain

From 3 different type of ESWT machinery (EP, EM, PE), all of them shared the same effect on pain domain from CPSI scoring system. Study from Ghazi et al., using EP Roland Pagani ES.WT machine showed significant improvement of pain symptom. The peak of the effect was reached for 6 months and lasted for 12 months after a month of ESWT treatment under specified protocol.9 Another study by Pajovic et al., utilized PE machine from Lubisone also demonstrated significant improvement compared to placebo 3 months and 6 months after 12 sessions of ESWT treatment.10 EM machine, the most frequently used in the study included, also showed another improvement in pain symptom. Kim et al. stated in their study that their machine (Cenowave medical) had improved their patients pain symptom in 1 month compared to placebo group.17 Pain improvement also recorded by Rayegani et al. with their Storz Medical EM machine 1 month and 3 months after 4 sessions of ESWT. Compared to placebo, the ESWT group had significant improvement in 1 month until 3 months of observations.14 Afterall, from the studies included in this systematic review, ESWT effect the pain relieve effect can last until 12 months. 3 different energy generator (EP, EM, PE) have similar effect regards the differences of the protocol that have been used in the last 10 years studies.

ESWT effect on urinating domain

In this systematic review we found 1 study stated that there was no significant improvement in urinating domain of CPSI. EM Cenowave medical that was utilized by Kim et al. showed no improvement after 1 months of observation in urinating domain. Small sample sized that was observed during the study and the length of follow up that only observed for 1 month may be the cause of this negative result.17 Meanwhile, the others showed statistically significant improvement in urinary symptoms after ESWT therapy. Ghazi et al. EP Roland Pagani ES.WT showed significant improvement even 12 months after 4 sessions of ESWT therapy compared to the.9 Another study from Pajovic et al., using PE Lubisone Machine protocol stated that ESWT enhanced the condition of the related symptom compared to the placebo.10 Ultimately another EM machine by Storz medical also presented significant improvement in 1 month and reached its peak in 3 months after 4 sessions of ESWT therapy.14 Despite single contradictive result from Kim et al., most of study showed significancy in rectify the urinary symptom in CP/CPPS patients. Therefore, bigger sample size and longer observation are needed to be done for further research.

ESWT effect on quality of life domain

The Quality of Life is one of three domain that was comprised in CPSI scoring system. It showed the satisfaction of patient with their condition subjectively. All of the study yielded in this review stated that the patient satiety in quality of life domain had been improved by the treatment of ESWT. EP Roland Pagani ESWT Machine showed significant improvement even in 1 month until 12 month after 4 sessions of ESWT treatment compared to the baseline.9 PE Lubisone machine also stated similar outcome that 4 sessions of ESWT treatment enhanced the quality of life of CP/CPPS patients with and last for 6 months.10 Likewise, an improvement to the quality of life had been reported from all EM machine studies, either by Storz or Cenowave medical. Kim et al. Cenowave medical showed improvement compared to placebo, and Rayegani et al. Storz medical showed positive result for the exact 1 month after ESWT protocol treatment14,16,17

ESWT effect on total domain

Despite the contradictive result from urinating domain by Kim et al., the overall calculation of CPSI domain showed an improvement from the studies included in our review (2 cohort studies and 3 RCT studies) that analysed each domain of CPSI. Another 2 studies from Sakr et al. and Wu et al., had demonstrated similar outcomes. Sakr et al. had found a significant improvement in total CPSI domain after 4 sessions of ESWT treatment compared to placebo within 12 months of observations.16 Meanwhile Wu et al., reported improvement only after 8 sessions of ESWT treatment resulted compared to the placebo.15 Otherwise, 1 study from Zhang et al. did not observe any significant improvement after 8 sessions of ESWT treatment.12 This phenomenon may be caused by the exclusion of 10 relapsing patients in this particular study. Other possible explanations for these findings may also be explained by the different protocol that have been used by Zhang et al. (10 Hz of Frequency with 0.18-0.2 mJ/mm2 of energy 1 session a week vs 3-4 Hz of frequency, 0.25 mJ/mm2 of energy flow density in other EM ESWT studies). Thus, the standardize protocol for ESWT machine need to be established for each energy generator used.12

These result from 8 studies that have been yielded, all 7 studies demonstrate the efficacy of ESWT treatment with 3 kind of machinery that available worldwide. The efficacy and safety of ESWT treatment for CP/CPPS patients had showing a good outcome with less adverse effect for the CP/CPPS patients in the maximum of 12 months of observation. The limitations of this systematic review is the restricted variety of energy generators with the lack of openly registered protocols. The lack of adherence to protocols and registration may give rise to the potential of biases and compromise the accuracy and transparancy of the review. This presents the risk of selective in the absence of pre-established protocols, which may later affect the validity of the findings.

Longer additional studies with longer observation are needed to be done in the future research in order to evaluate the efficacy and safety protocol of ESWT on CP/CPPS. Even with the benefit of ESWT usage for CP/CPPS, the standardize protocols are needed to enhance the outcome of the patients. The variety of machine and brand are sometime confuse the operator to set the protocol for each machine, and moreover, some of the brands are not displaying the energy flow density on its devices. Therefore, this review is comparing the protocol and the outcome that has been observed for the last 10 years. Hopefully, this review can be a suggestion and a guidance for many clinician or researcher to be applied in daily practice or to be an insight for further research.

Conclusion

ESWT treatment has showed its effect on CP/CPPS patients. Regardless from the type of machinery or the brand that used, the efficacy and safety of ESWT treatment showed a better outcome than the conventional oral medications alone in 12 months of observations. Although have the same efficacy, the protocol for each type of machinery is different. Therefore, this systematic review provide some insight for clinician on how clinical protocol are established for every energy generator that used in daily practice. Additional studies are needed to evaluate the efficacy of ESWT on EP/CPPS for longer duration of observation. Finally, further research must be conducted to establish the standardized protocol for shockwave delivery.

Registration and protocol

The evaluation was undertaken without previous registration and without any registered processes.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 18 Oct 2023
Comment
Author details Author details
Competing interests
Grant information
Copyright
Download
 
Export To
metrics
Views Downloads
F1000Research - -
PubMed Central
Data from PMC are received and updated monthly.
- -
Citations
CITE
how to cite this article
mikha M and Ardianson Deswanto I. The therapeutic effect and safety profile of extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: a systematic review [version 1; peer review: 1 approved with reservations]. F1000Research 2023, 12:1363 (https://doi.org/10.12688/f1000research.140828.1)
NOTE: If applicable, it is important to ensure the information in square brackets after the title is included in all citations of this article.
track
receive updates on this article
Track an article to receive email alerts on any updates to this article.

Open Peer Review

Current Reviewer Status: ?
Key to Reviewer Statuses VIEW
ApprovedThe paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approvedFundamental flaws in the paper seriously undermine the findings and conclusions
Version 1
VERSION 1
PUBLISHED 18 Oct 2023
Views
5
Cite
Reviewer Report 14 May 2024
Biagio Barone, AORN Sant’Anna e San Sebastiano, Caserta, Italy 
Approved with Reservations
VIEWS 5
General comment:
The manuscript entitled “The therapeutic effect and safety profile of extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: a systematic review” by Mikha and Deswanto, aims to compare the clinical protocol, efficacy and safety ... Continue reading
CITE
CITE
HOW TO CITE THIS REPORT
Barone B. Reviewer Report For: The therapeutic effect and safety profile of extracorporeal shockwave therapy in treatment of chronic prostatitis/chronic pelvic pain syndrome: a systematic review [version 1; peer review: 1 approved with reservations]. F1000Research 2023, 12:1363 (https://doi.org/10.5256/f1000research.154228.r231990)
NOTE: it is important to ensure the information in square brackets after the title is included in all citations of this article.

Comments on this article Comments (0)

Version 1
VERSION 1 PUBLISHED 18 Oct 2023
Comment
Alongside their report, reviewers assign a status to the article:
Approved - the paper is scientifically sound in its current form and only minor, if any, improvements are suggested
Approved with reservations - A number of small changes, sometimes more significant revisions are required to address specific details and improve the papers academic merit.
Not approved - fundamental flaws in the paper seriously undermine the findings and conclusions
Sign In
If you've forgotten your password, please enter your email address below and we'll send you instructions on how to reset your password.

The email address should be the one you originally registered with F1000.

Email address not valid, please try again

You registered with F1000 via Google, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Google account password, please click here.

You registered with F1000 via Facebook, so we cannot reset your password.

To sign in, please click here.

If you still need help with your Facebook account password, please click here.

Code not correct, please try again
Email us for further assistance.
Server error, please try again.